Bayer, Reckitt among final contenders for Merck consumer health care unit
Merck & Co. Inc. is in the final stages of selling its consumer health care unit for nearly $14 billion, with Bayer AG and Reckitt Benckiser Group Plc among final contenders to clinch a deal as soon as this week, people familiar with the matter said.
Germany's Bayer and British consumer products giant Reckitt have emerged as front-runners to win the auction after each offering about $13.5 billion for the Merck consumer unit, best known for Coppertone sunscreen and Claritin allergy medicine, the sources said.
Both bidders are very keen to buy the asset, and the price tag could go higher in the final days, one person added. All the people asked not to be named because the matter is not public.
Representatives of American drugmaker Merck, as well as Bayer and Reckitt, declined to comment.
Show commenting policy
TribLive commenting policy
- Top U.S. general wants more troops in Afghanistan
- Hillary Clinton kept in touch with key donors, emails show
- Despite sunny forecast, South Carolina ordeal far from over
- Top general in Afghanistan: U.S. strike on hospital a mistake
- Deal close on Pacific free trade pact
- South Carolina flood: Door-to-door searches, swamped roads
- Redesigned Confederate flag license plate on sale in Ga.
- Oregon’s legal pot sales to begin with party
- Oregon shooter a lonely youth with grudge against religion
- Rains drench saturated East Coast
- California vineyards skip irrigation amid drought